Skip to content
10-Q

Quarterly Report

Decibel Therapeutics, Inc.

0000950170-23-021967

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 1, 2023 25.01M sh
Shares Diluted Q1 2023 · Mar 31, 2023 24.99M sh
Shares Diluted Q1 2023 · Mar 31, 2022 24.96M sh
Capex Q1 2023 · Mar 31, 2023 $266K
Capex Q1 2023 · Mar 31, 2022 $101K
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$17.06M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$22.01M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $38.07M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $34.61M
Cash And Equivalents Q1 2023 · Mar 31, 2022 $10.78M
Stockholders Equity Q1 2023 · Mar 31, 2023 $69.84M
Stockholders Equity Q1 2023 · Dec 31, 2022 $81.79M
Stockholders Equity Q1 2023 · Mar 31, 2022 $128.12M
Stockholders Equity Q1 2023 · Dec 31, 2021 $141.69M
Current Liabilities Q1 2023 · Mar 31, 2023 $23.18M
Current Liabilities Q1 2023 · Dec 31, 2022 $22.44M
Total Liabilities Q1 2023 · Mar 31, 2023 $40.61M
Total Liabilities Q1 2023 · Dec 31, 2022 $41.58M
Current Assets Q1 2023 · Mar 31, 2023 $95.87M
Current Assets Q1 2023 · Dec 31, 2022 $108.03M
Total Assets Q1 2023 · Mar 31, 2023 $110.45M
Total Assets Q1 2023 · Dec 31, 2022 $123.37M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.53
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.56
Eps Basic Q1 2023 · Mar 31, 2023 −$0.53
Eps Basic Q1 2023 · Mar 31, 2022 −$0.56
Sga Expense Q1 2023 · Mar 31, 2023 $6.19M
Sga Expense Q1 2023 · Mar 31, 2022 $6.55M
Rd Expense Q1 2023 · Mar 31, 2023 $7.93M
Rd Expense Q1 2023 · Mar 31, 2022 $7.47M
Net Income Q1 2023 · Mar 31, 2023 −$13.3M
Net Income Q1 2023 · Mar 31, 2022 −$14.02M
Operating Income Q1 2023 · Mar 31, 2023 −$14.12M
Operating Income Q1 2023 · Mar 31, 2022 −$14.02M